Publicaciones (376) Publicaciones en las que ha participado algún/a investigador/a Ver datos de investigación referenciados.

2024

  1. Advances in mechanotransduction and sonobiology: effects of audible acoustic waves and low-vibration stimulations on mammalian cells

    Biophysical Reviews

  2. Eco-Friendly and Biocompatible Material to Reduce Noise Pollution and Improve Acoustic Comfort in Healthcare Environments

    Buildings, Vol. 14, Núm. 10

  3. Exploring the Effects of Gratitude Voice Waves on Cellular Behavior: A Pilot Study in Affective Mechanotransduction

    Applied Sciences (Switzerland), Vol. 14, Núm. 20

  4. Immunohistochemical, functional, and anatomical evaluation of patients with idiopathic epiretinal membrane

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 262, Núm. 5, pp. 1443-1453

  5. Importance of Visual Support Through Lipreading in the Identification of Words in Spanish Language

    Language and Speech

  6. Neuroinflammation as a cause of differential Müller cell regenerative responses to retinal injury

    Science advances, Vol. 10, Núm. 40, pp. eadp7916

  7. Neuronal and glial cell alterations involved in the retinal degeneration of the familial dysautonomia optic neuropathy

    GLIA, Vol. 72, Núm. 12, pp. 2268-2294

  8. Non-haematopoietic Sca-1+ Cells in the Retina of Adult Mice Express Functional TLR2

    Stem Cell Reviews and Reports, Vol. 20, Núm. 3, pp. 845-851

  9. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7

    Cell Calcium, Vol. 123

2023

  1. A Slc38a8 Mouse Model of FHONDA Syndrome Faithfully Recapitulates the Visual Deficits of Albinism Without Pigmentation Defects

    Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 32

  2. ASCL1 induces neurogenesis in human Müller glia

    Stem Cell Reports, Vol. 18, Núm. 12, pp. 2400-2417

  3. Anakinra para el tratamiento de la COVID-19

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 3, pp. 230-231

  4. Anticuerpos dirigidos contra el β-amiloide para el tratamiento de la enfermedad de Alzheimer

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 3, pp. 232-234

  5. Aprobado en los Estados Unidos por la vía acelerada el uso de lecanemab para el tratamiento de la enfermedad de Alzheimer

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 1, pp. 61-62

  6. Colirios con alcanos semifluorados: ¿nuevos tiempos para el tratamiento del ojo seco?

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 1, pp. 57-58

  7. Correction: Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patients (Translational Neurodegeneration, (2023), 12, 1, (17), 10.1186/s40035-023-00348-y)

    Translational Neurodegeneration

  8. Deucravacitinib: un nuevo tratamiento oral para la psoriasis en placas de moderada a grave

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 2, pp. 130-131

  9. Editorial: How do we see? Morphology and physiology of retinal neurons

    Frontiers in Neuroanatomy

  10. Editorial: Understanding retinal remodeling: Retinal alterations and therapeutic implications

    Frontiers in Neuroanatomy

  11. Expression of two major isoforms of MYO7A in the retina: Considerations for gene therapy of Usher syndrome type 1B

    Vision Research, Vol. 212